Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of Tritanrix-HepB/Hib-MenAC Vaccine in Infants
NCT00291967Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2002
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Tritanrix-HepB/Hib-MenAC in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Nov 2002; status: completed.
02
Drugs
Tritanrix-HepB/Hib-MenAC
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00291967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00291967.